Pharmafile Logo

Lucid Group Achieve UK’s Highest Award for Business Success

- PMLiVE

Lucid Group have been chosen to receive a Queen’s Award for Enterprise in International Trade. This award is widely regarded as the UK’s highest accolade for business success and they are delighted to have been recognised.

Lucid Group is a strategic medical communications company that recently celebrated its ten year anniversary. This award confirms the success of its first decade of trading which has seen its international trade grow exponentially over recent years.

Lucid has developed a very effective strategy, segmenting its market basically into two, recognizing the great differences in business cultures between its largest market, the USA, which is dealt with through its office in New York and represents 66% of overseas sales; and the rest of the world, serviced from the UK. Exports grew by 61% in three years and as a proportion of total sales increased from 63% to 81%.

Lucid is no stranger to winning awards and holds a number of industry-related prizes. In 2015 Lucid scooped the Medical Education Consultancy of the Year title at Communiqué for the third year in a row, confirming its position as the leader and innovator in medical education at a global, regional and national level. Now for the first time its expertise and business success has been judged against a diverse array of companies from different types of industries.

Jan Steele (Lucid Co-founder and COO) commented “Winning a Queen’s Award for Enterprise is a tremendous honour for everyone who has contributed to our success. Our shared passion and vision to improve patient outcomes via behaviour change and strategic communication programmes is unrelenting and is the key to our winning formula. To be granted such a prestigious award in a category where we were competing with very diverse businesses makes us very proud.”

To find out more about Lucid and what they do please visit www.Lucid-group.co.uk

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

Lucid celebrate big wins at PMEA 2015

Success for Lucid at PMEA 2015

Lucid invests in their Futures programme with a new hire

Lucid Group continues their expansion

Janus kinase inhibitors are amongst the most read abstracts at the American College of Rheumatology 2015

Rheumatologists eagerly await trial data for Janus kinase inhibitors

Making a difference to patients with IBD

Changing lives with medical education

Lucid Group showcases new KOL identification and mapping tool

Advancing Expert identification with digital new tool from Lucid Group

Lucid CEO discusses his inspiration and passion for changing patients’ lives

Changing patients' lives with innovative methodologies in medical education

Lucid Group starts new trend for CME in IBD education

A tailored educational event in IBD